Search - tctmd.com

Displaying 121 - 136 of 136

Sort: Relevancy | Date

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Daily News

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

Todd Neale

March 14, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

News Daily News

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

Michael O'Riordan

January 31, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Todd Neale

December 05, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Stroke Not the Only Concern in Patients With A-fib

Todd Neale

September 07, 2016

News Daily News

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

Yael L. Maxwell

August 16, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

L.A. McKeown

July 19, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

Advertisement

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular Stories for February 2017

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

TCTMD’s Top 10 Most Popular News and Features for 2016

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

TCTMD’s Top 10 Most Popular Stories for November 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Stroke Not the Only Concern in Patients With A-fib

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content